Original Article
Basal 18F-FDG PET/CT as a predictive biomarker of tumor response for neoadjuvant therapy in breast cancer
18F-FDG PET/TC basal como biomarcador predictor de respuesta tumoral al tratamiento neoadyuvante en el cáncer de mama
A.M. García Vicentea,
, A. Soriano Castrejóna, R.E. Pruneda-Gonzálezb, G. Fernández Calvob, M.M. Muñoz Sánchezc, R. Álvarez Cabellosd, R. Espinosa Aunióne, F. Relea Calatayudf
Corresponding author
a Nuclear Medicine Department, University General Hospital, Ciudad Real, Spain
b Department of Mathematics & IMACI-Institute of Applied Mathematics in Science and Engineering, University of Castilla-La Mancha, Ciudad Real, Spain
c Oncology Department, Virgen de la Luz Hospital, Cuenca, Spain
d Oncology Department, Virgen de la Salud Hospital, Toledo, Spain
e Oncology Department, La Mancha Centro Hospital, Alcázar de San Juan, Ciudad Real, Spain
f Pathology Department, University General Hospital, Ciudad Real, Spain
